RBC Bioscience Corporation (TPEX:6848)
Taiwan · Delayed Price · Currency is TWD 21.30
-0.45 (-2.07%)
Sep 11, 2026, 2:05 PM CST
RBC Bioscience Market Cap
RBC Bioscience has a market cap or net worth of 309.74 million as of September 11, 2026. Its market cap has increased by 17.93% in one year.
Market Cap
309.74M
Enterprise Value
655.41M
Revenue
220.60M
Ranking
n/a
PE Ratio
14.76
Stock Price
21.30
ChartMarket Cap Chart
Since October 25, 2021, RBC Bioscience's market cap has decreased from 632.27M to 309.74M, a decrease of -51.01%. That is a compound annual growth rate of -13.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 309.74M | 28.78% |
| Dec 31, 2025 | 240.51M | -2.96% |
| Dec 31, 2024 | 247.83M | 17.90% |
| Dec 29, 2023 | 210.20M | 2.21% |
| Dec 30, 2022 | 205.66M | -55.24% |
| Dec 30, 2021 | 459.45M | -27.33% |
| Oct 25, 2021 | 632.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 768.22M |
| Lukas Biomedical | 766.30M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 711.93M |
| Taiwan Advance Bio-Pharmaceutical | 644.40M |
| SynCore Biotechnology Co.,Ltd | 641.76M |
| LAUNXP Biomedical | 563.09M |
| TaiwanJ Pharmaceuticals | 551.24M |